Characteristics | Bivariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR and 95% CI | p-value | HR and 95% CI | p-value | |
Agea | ||||
≤70 | 1 | |||
>70 | 0.44 [0.15; 1.28] | 0.13 | - | - |
Stage | ||||
T1c + 2a | 1 | |||
T2b | 1.68 [0.52; 5.46] | 0.39 | ||
T2c-T4 | 0.69 [0.15; 3.19] | 0.63 | ||
Diabetes | ||||
No | 1 | |||
Yes | 1.84 [0.59; 5.80] | 0.30 | ||
HBP | ||||
No | 1 | |||
Yes | 0.55 [0.20; 1.53] | 0.25 | ||
Pelvic surgery | ||||
No | 1 | |||
Yes | 0.89 [0.32; 2.52] | 0.84 | ||
Previous TURP | ||||
No | 1 | |||
Yes | 0.98 [0.22; 4.36] | 0.98 | ||
ADTa | ||||
No | 2.46 [0.78;7.74] | 0.12 | ||
Yes | 1 | |||
Anticoagulation treatmenta | ||||
No | 1 | |||
Yes | 1.30 [0.47; 3.59] | 0.61 | - | - |
RTH total dose | ||||
70 Gy | 1 | |||
74 Gy | 1.06 [0.13;8.82] | 0.96 | ||
80 Gy | 3.12 [0.39;24.98] | 0.28 | ||
RTH total dosea | ||||
70Gy-74Gy | 1 | |||
80 Gy | 2.96 [1.07; 8.20] | 0.04 | 2.96 [1.07; 8.20] | 0.04 |